Dr. Frank D. Cirisano MD,
Academic Appointments:
1995 – 1998 Clinical Instructor and Associate Physician Department of Obstetrics & Gynecology Duke University Medical Center
Licensure:
1997 Florida Certification:
1992 Diplomate, National Board of Medical Examiners
1998 Candidate, American Board of Obstetrics Gynecology
1998 Candidate, American Board of Obstetrics Gynecology, Division of Gynecologic Oncology
Education:
Colgate University Biological Sciences
1985 B.A. Hamilton, NY;Cum Laude Columbia University Medicine;
1990; M.D. New York, NY UCLA-Cedars-Sinai Obstetrics/Gynecology
1994 Residency Medical Center Los Angeles, CA UCLA-Cedars-Sinai Molecular Biology
1995 Post-doctoral Medical Center Research Los Angeles, Fellowship Duke University Gynecologic Oncology
1998 Clinical Durham, NC Fellowship Honors
1998 Duke University Distinguished Professor’s Teaching Award
1997 SGO Most Outstanding Basic Science Poster
1996 AACR Distinguished Poster and Travel Award
1995 Most Outstanding Resident and Fellow MAGOS Presentation
1994 Saul Fox Honoree for Resident Research
1994 Chairman’s Award for Most Outstanding Resident
1994 Paul Rubenstein Resident Research Finalist Award
1994 CIGNA Most Outstanding Overall Resident Award
1994 CIGNA Most Outstanding Fourth Year Resident Award
1993 American Association of Gynecologic Laparoscopists Excellence in Endoscopic Procedures
Award, Honorary Membership and Meeting Stipend
1993 Saul Fox Honoree for Resident Research
1993 TAP Pharmaceutical Honorarium, Management of Endometriosis Lecture
1993 First Recipient, Resident of Excellence Teaching Award
1993 CIGNA Most Outstanding Overall Resident Award
1993 CIGNA Most Outstanding Third Year Resident Award
1992 CIGNA Most Outstanding Second Year Resident Award
1985 Honors in Biology, Colgate University Scholarships
1993 Galloway Fellowship, Memorial Sloane-Kettering Cancer Center
1990 Aaron Diamond Foundation Health Care Scholarship, Colgate University
1986 Nathaniel B. Stanton Scholarship for Medical Education, Colgate University
1981-1985 New York State Undergraduate Regents Scholarship
Memberships
1985-present Tri Beta Biology Honor Society, Colgate University
1982-present Phi Eta Sigma Freshman Honor Society, Colgate University
1990-present Columbia University Physicians and Surgeons Alumni Association
1992-present Junior Fellow, American College of Obstetrics & Gynecology
1993-1995 Los Angeles County Medical Association
1993-present American Association of Gynecologic Laparoscopists
1994-present Daniel Morton Society, UCLA Medical Center
1999-present Board Member, American Cancer Society
1999-present Board Member, Cancer Research Network Administrative Responsibilities
1999-present Cancer committee, Aventura Hospital and Comprehensive Cancer Center
1999-present Cancer committee, Memorial Regional Cancer Center
1999-present Education committee, American Cancer Society
1998-present Informatics committee, Florida Society of Gynecologic Oncologists
1993-1994 Administrative Chief Resident, Obstetrics and Gynecology
1993-1994 Resident Selection Committee
1992-1994 Utilization Management Committee, Obstetrics and Gynecology
1992-1994 Resident Education Committee Publications -
Peer Reviewed
1. Cirisano FD, Greenspoon JS, Stenson R, Farias-Eisner R, Karlan BY, Lagasse LD: The etiology and management of diarrhea in the gynecologic oncology patient. Gynecol Oncol 50:45-48, 1993.
2. Farias-Eisner RF, Cirisano FD, Grouse D, Leuchter R, Karlan BY, Lagasse LD, Berek JS: Conservative and individualized surgery for early squamous carcinoma of the vulva: The treatment of choice for stages I & II (T1-2 N0-1 M0) disease. Gynecol Oncol 53:55-58, 1994.
3. Farias-Eisner R, Cirisano FD, Berek JS: ACOG human papilloma virus - computer interaction program. American College of Obstetrics and Gynecology Teaching Series, (1994).
4. Karlan BY, Baldwin RL, Cirisano FD, Mamula PW, Jones JJ, Lagasse LD: Secreted ovarian epithelial substance inhibits ovarian epithelial cell proliferation. Gynecol Oncol & 59:67-74, 1995.
5. Casey AC, Farias-Eisner R, Pisani AL, Cirisano FD, Kim YB, Muderspach L, Futoran R, Leuchter RS, Lagasse LD, Karlan BY: What is the role of reassessment laparoscopy in the management of gynecologic cancers in 1995? Gynecol Oncol 60:454-61, 1996.
6. Cirisano FD, Lee S, Greenspoon JS: Apparent heparin resistance due to elevated factor VIII in a patient with post-operative deep venous thrombosis: Case Report. J Repro Med 41;3:191-194, 1996.
7. Vaughn JP, Cirisano FD, Huper G, Berchuck A, Futreal PA, Marks JR, Iglehart JD: Cell Cycle Control of BRCA2. Cancer Research 56:4590-4594, 1996.
8. Berchuck A, Cirisano FD, Lancaster J, Schildkraut JM, Wiseman RW, Futreal A, Marks JR: Role of BRCA1 mutation screening in the management of familial ovarian cancer. Am J Obstet Gynecol 175:738-746, 1996.
9. Elbendary A, Cirisano FD, Evans AC, Jr., Davis PL, Iglehart JD, Marks JR, Berchuck A: Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res 2:1571-1575, 1996.
10. Ng WL, Schummer M, Cirisano FD, Baldwin RL, Karlan BY, Hood LE: High-throughput plasmid mini preparations facilitated by micro-mixing. Nucleic Acids Res 24(24):5045-5047, 1996. 11. Clifford SL, Kaminetsky CP, Cirisano FD, Dodge R, Soper JT, Clarke-Pearson DL, Berchuck A: Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer. Am J Obstet Gynecol 176 (6):S229-S232, 1997.
12. Eachempati SR, Young C, Alexander J, Cirisano FD, Rodriguez GC, Reed II, RL: The use of esophageal doppler monitoring in a patient with early intracardiac Greenfield filter migration. J Vasc Surg (In Press).
13. Cirisano FD, Soper JT. Clinical management of gestational trophoblastic disease. Primary Care Ob/Gyn. March 1998; 4: 4-8.
14. Ng WL, Schummer M, Bumgarner RE, Cirisano, FD, Baldwin RL, Karlan BY and Hood L. High-density cDNA array expression mapping of human ovarian tumors. Proc Amer Assoc Cancer Res 1996; 37: 517.
15. Cirisano FD. Management of Preinvasive disease of the cervix. Seminars in Surgical Oncology. 1999; In Press.
16. Gilliam LK, Scearce RM, Cirisano FD, Lobenhofer E, Marks JR, Hale LP. Production of a monoclonal antibody reactive with BRCA2 protein sequences. Proceedings of the American Association for Cancer Research 1997; 38: 243.
17. Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL. Epidemiologic and surgico-pathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol 1999; 74: 385-393.
18. Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers compared with endometrioid carcinoma. Gynecol Oncol 1999 (in press).
Publications - Non-Peer Reviewed
1. Cirisano FD, Mattox TF, Greenspoon JS:DobyWIN v3.00 computer software patient database application. 8 1995 Cirisano, Mattox and Greenspoon.
2. Berchuck A, Cirisano FD: Pathogenesis of ovarian cancer: Role of ovulation and molecular changes. The Ovary: Regulation, Dysfunction and Treatment, (Filicori, M, ed) Elsevier Science B.V., Amsterdam. pp. 267-273, 1996.
3. Cirisano FD, Karlan BY: The role of HER-2/neu oncogene in gynecologic cancers. J Soc Gynecol Invest 1966;3:99-105, 1996.
4. Berchuck A, Cirisano FD. Genetics and molecular biology of granulosa-theca cell tumors of the ovary. CME J Gynecol Onc (3) 127-131, 1996.
5. Cirisano FD, Berchuck A: Current understanding/management of granulosa-theca cell tumors of the ovary. Postgraduate Obstetrics Gynecology 1996.
7. Berchuck A, Cirisano FD: Genetics of ovarian cancer. The Endocrinologist (in press).
8. Berchuck A, Cirisano FD: Endometrial carcinoma. Current Therapy in Obstetrics and Gynecology (Zuspan FP, Quilligan EJ eds), 5th Edition. WB Saunders Co, 2000.
9. Cirisano FD. Ovarian cancer genetics.
Updates from Memorial Regional Cancer Center
1998; 2: 1-6. 10. Cirisano FD. Preinvasive disease of the cervix. Updates from Memorial Regional Cancer Center 1998; 2: 2-13
